FDA Clearance Tracker · P980044-S027
VISCO-3
Last checked: Nov 20, 2026Latest source record: Dec 21, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2015
Approved
Time to decision
166 days
Received Jul 8, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P980044-S027
- Device name
- VISCO-3
- Applicant
- Seikagaku Corp.
- Applicant location
- Tokyo
- Received
- Jul 8, 2015
- Decided
- Dec 21, 2015
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P980044
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR VISCO-3. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.
Source documents
Other decisions for Seikagaku Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GEL-ONE(R)PMA supplement
P080020-S020 · Decided Sep 27, 2016 · 179 days after receipt · Panel Track
Device type: Acid, hyaluronic, intraarticular (MOZ) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.